PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsAmphetamine
Amphetamine
Adderall, Adzenys, Amphetamine, Amphetamine / Amphetamine / Dextroamphetamine / Dextroamphetamine, Biphetamine, Delcobese, Dyanavel, Evekeo, Mydayis (amphetamine) is a small molecule pharmaceutical. Amphetamine was first approved as Delcobese on 1982-01-01. It is used to treat attention deficit disorder with hyperactivity and narcolepsy in the USA. The pharmaceutical is active against sodium-dependent dopamine transporter and sodium-dependent noradrenaline transporter. In addition, it is known to target carbonic anhydrase 5A, mitochondrial, trace amine-associated receptor 1, and carbonic anhydrase 7.
Download report
Favorite
Top Prescription Drugs
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nervous system diseasesD009422
mental disordersD001523
Trade Name
FDA
EMA
Adzenys, Amphetamine, Evekeo (discontinued: Adzenys, Amphetamine, Evekeo)
Combinations
Adderall, Dextroamp saccharate, amp aspartate, dextroamp amp, Dyanavel, Mydayis (discontinued: Adderall, Biphetamine, Delcobese, Dextroamp saccharate, amp aspartate, dextroamp amp, Dextroamp saccharate,amp aspartate,dextroamp amp)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Amphetamine aspartate
+
Amphetamine sulfate
+
Dextroamphetamine saccharate
+
Dextroamphetamine sulfate
Tradename
Company
Number
Date
Products
ADDERALL XR 10TakedaN-021303 RX2001-10-11
1 products, RLD
ADDERALL XR 20TakedaN-021303 RX2001-10-11
1 products, RLD
ADDERALL XR 30TakedaN-021303 RX2001-10-11
1 products, RLD, RS
ADDERALL XR 25TakedaN-021303 RX2002-05-22
1 products, RLD
ADDERALL XR 5TakedaN-021303 RX2002-05-22
1 products, RLD
ADDERALL XR 15TakedaN-021303 RX2002-05-22
1 products, RLD
MYDAYISTakedaN-022063 RX2017-06-20
4 products, RLD, RS
Show 7 discontinued
Amphetamine
+
Amphetamine aspartate
+
Dextroamphetamine sulfate
Tradename
Company
Number
Date
Products
DYANAVEL XRTris PharmaN-208147 RX2015-10-19
1 products, RLD, RS
DYANAVEL XR 5Tris PharmaN-210526 RX2021-11-04
1 products, RLD
DYANAVEL XR 10Tris PharmaN-210526 RX2021-11-04
1 products, RLD
DYANAVEL XR 15Tris PharmaN-210526 RX2021-11-04
1 products, RLD
DYANAVEL XR 20Tris PharmaN-210526 RX2021-11-04
1 products, RLD, RS
Amphetamine sulfate
Tradename
Company
Number
Date
Products
EVEKEO ODTAzurityN-209905 DISCN2019-01-30
5 products, RLD
Hide discontinued
Amphetamine
Tradename
Company
Number
Date
Products
ADZENYS XR-ODTNeos TherapeuticsN-204326 RX2016-01-27
6 products, RLD, RS
Show 1 discontinued
Amphetamine resin complex
+
Dextroamphetamine resin complex
Tradename
Company
Number
Date
Products
BIPHETAMINE 20UCBN-010093 DISCN1982-01-01
1 products
BIPHETAMINE 12.5UCBN-010093 DISCN1982-01-01
1 products
BIPHETAMINE 7.5UCBN-010093 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
adderallNew Drug Application2025-09-23
adderall xrNew Drug Application2010-03-29
adzenys xr-odtNew Drug Application2025-04-02
amphetamine extended-releaseNDA authorized generic2025-08-22
amphetamine sulfateANDA2025-10-01
dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfateANDA2023-10-20
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfateANDA2025-08-04
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfateANDA2024-02-05
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-releaseANDA2024-02-01
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfateANDA2025-07-18
Show 12 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
narcolepsyEFO_0000614D009290G47.4
attention deficit disorder with hyperactivityEFO_0003888D001289F90
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Amphetamine / Amphetamine Aspartate/Dextroamphetamine Sulfate, Dyanavel Xr 10, Tris Pharma Inc
115900812038-09-24DPU-3538
83378902027-03-15DP
96757042027-03-15DP
Amphetamine Sulfate, Evekeo Odt, Azurity
104415542037-03-10DP
111607722037-03-10DP
118965622037-03-10U-3299
101305802024-04-19DP
Amphetamine / Amphetamine Aspartate/Dextroamphetamine Sulfate, Dyanavel Xr, Tris Pharma Inc
115902282036-09-07DPU-3538
80626672029-03-29DP
85976842027-03-15DP
87479022027-03-15DP
88832172027-03-15DP
96757032027-03-15DP
100860872027-03-15DP
Amphetamine, Adzenys Er, Neos Theraps Inc
87094912032-06-28DP
90177312032-06-28DP
92657372032-06-28DP
Amphetamine Aspartate / Amphetamine Sulfate / Dextroamphetamine Saccharate / Dextroamphetamine Sulfate, Mydayis, Takeda Pharms Usa
88461002029-08-24DP
91738572026-05-12U-2025
Amphetamine, Adzenys Xr-Odt, Neos Theraps
88409242026-04-09DP
ATC Codes
N: Nervous system drugs
— N06: Psychoanaleptics
— N06B: Psychostimulants, agents used for adhd and nootropics
— N06BA: Centrally acting sympathomimetics
— N06BA01: Amfetamine
HCPCS
Code
Description
S0160
Dextroamphetamine sulfate, 5 mg
Clinical
Clinical Trials
454 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Attention deficit disorder with hyperactivityD001289EFO_0003888F90820224122108
HyperkinesisD006948——51215201462
Amphetamine-related disordersD019969EFO_0004701F15912521944
Substance-related disordersD019966EFO_0003890F13149231642
ObesityD009765EFO_0001073E66.937613533
Cocaine-related disordersD019970—F14121411529
Depressive disorderD003866EFO_1002014F32.A—655218
DepressionD003863—F33.9—654217
SchizophreniaD012559EFO_0000692F202441414
Major depressive disorderD003865EFO_0003761F22—433212
Show 46 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Post-traumatic stress disordersD013313EFO_0001358F43.14275—337
Traumatic stress disordersD040921——2213—328
BulimiaD002032—F50.2147—113
Binge-eating disorderD056912—F50.2147—113
Addictive behaviorD016739EFO_0004347——51—712
Heroin dependenceD006556EFO_0004240———3—25
Drug therapyD004358———21——2
Marijuana abuseD002189EFO_0007191F12—11—12
Multiple sclerosisD009103EFO_0003885G35—21——2
Prediabetic stateD011236EFO_1001121R73.03——1——1
Show 5 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———292——738
Opioid-related disordersD009293EFO_0005611F11—2——57
AlcoholismD000437EFO_0003829F10.112——25
NarcolepsyD009290EFO_0000614G47.421——14
Alcohol drinkingD000428EFO_0004329—12——14
Mental disordersD001523EFO_0000677F91.9—1——23
NeoplasmsD009369—C80—3———3
Heart diseasesD006331EFO_0003777I51.9—1——12
Obsessive-compulsive disorderD009771EFO_0004242F42—1——12
AnhedoniaD059445—R45.8411———2
Show 26 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Mood disordersD019964EFO_0004247F30-F396———17
Tobacco use disorderD014029—F171———34
HypertensionD006973EFO_0000537I101———12
PainD010146EFO_0003843R521———12
PharmacokineticsD010599——2————2
Social interactionD000083505——2————2
MetabolismD008660GO_0008152—1————1
Cardiovascular abnormalitiesD018376EFO_0003848—1————1
Drug interactionsD004347——1————1
Drug misuseD000076064——1————1
Show 9 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HivD006678—O98.7————33
SyndromeD013577——————33
Metabolic syndromeD024821EFO_0000195E88.810————33
HyperglycemiaD006943—R73.9————22
CravingD066249——————22
Personality disordersD010554—F60.6————22
HemorrhageD006470MP_0001914R58————11
Heart failureD006333EFO_0003144I50————11
Covid-19D000086382—U07.1————11
InfectionsD007239EFO_0000544—————11
Show 52 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAmphetamine
INNamfetamine
Description
1-phenylpropan-2-amine is a primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
Classification
Small molecule
Drug classCNS stimulant, anorectic
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(N)Cc1ccccc1
Identifiers
PDB—
CAS-ID300-62-9
RxCUI—
ChEMBL IDCHEMBL405
ChEBI ID2679
PubChem CID3007
DrugBankDB00182
UNII IDCK833KGX7E (ChemIDplus, GSRS)
Target
Agency Approved
SLC6A3
SLC6A3
SLC6A2
SLC6A2
Organism
Homo sapiens
Gene name
SLC6A3
Gene synonyms
DAT1
NCBI Gene ID
6531
Protein name
sodium-dependent dopamine transporter
Protein synonyms
DA transporter, dopamine transporter 1, solute carrier family 6 (neurotransmitter transporter), member 3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, Solute carrier family 6 member 3
Uniprot ID
Q14996
Mouse ortholog
Slc6a3 (13162)
sodium-dependent dopamine transporter (Q9R1I2)
Alternate
CA5A
CA5A
TAAR1
TAAR1
CA7
CA7
Organism
Homo sapiens
Gene name
CA5A
Gene synonyms
CA5
NCBI Gene ID
763
Protein name
carbonic anhydrase 5A, mitochondrial
Protein synonyms
CA-VA, Carbonate dehydratase VA, carbonic anhydrase V, mitochondrial, Carbonic anhydrase VA, carbonic anhydrase VA, mitochondrial, carbonic dehydratase
Uniprot ID
P35218
Mouse ortholog
Car5a (12352)
carbonic anhydrase 5A, mitochondrial (P23589)
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Adderall – Shire
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Adderall – Takeda
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Mydayis – Shire
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Adzenys – Neos Therapeutics
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Amphetamine
+
Dextroamphetamine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 57,243 documents
View more details
Safety
Black-box Warning
Black-box warning for: Adderall, Adderall xr, Adzenys xr-odt, Amphetamine extended-release, Amphetamine sulfate, Dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release, Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate, Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets,cii, Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate, Dyanavel xr, Evekeo, Mixed salts of a single entity amphetamine product, Mixed salts of a single-entity amphetamine product, Mydayis
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
53,995 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use